GeneSet Information

Tier IV GS410172 • MAGMA gene-based results for non-substance use (non-SU) externalizing (EXT) factor_pvalue

DESCRIPTION:

GWAS summary statistics were selected from publicly-available GWAS of individuals of European ancestry on a variety of internalizing, externalizing, and substance use traits. Selection of externalizing psychopathology and substance use traits was partly based on a recent genomic SEM investigation of externalizing and included three measures of substance use: lifetime cannabis use (N=162,082), lifetime smoking initiation (N=632,802), and the number of alcoholic drinks per week (N=537,349). Additionally, we included four measures of non-substance use externalizing problems, including attention-deficit/hyperactivity disorder (ADHD; N=55,290), general risk tolerance and speeding behavior (N=939,908), reverse-coded age at first sexual intercourse (N=317,694) and number of sexual partners (N=370,711) obtained from the UK Biobank (http://www.nealelab.is/uk-biobank/), and antisocial behavior. Target data were drawn from the National Longitudinal Study of Adolescent to Adult Health (Add Health), a nationally representative sample of 20,745 youth starting in grades 7-12 in the United States. Specifically, substance use and demographic data were drawn from the Wave IV survey, which occurred from 2008-2009, on a subset of participants (N=15,071). Participants ranged in age from 24-34 (mean age=28.98 years; SD=1.75). The three resulting higher-order factors represented: 1) substance use (SU)-related psychopathology (including variance shared across substance use, internalizing, and externalizing psychopathology), 2) variance in internalizing traits not related to substance use (non-SU internalizing), and 3) variance in externalizing traits not related to substance use (non-SU externalizing). We calculated the effective n’s for each factor consistent with the approach in Demange, Malanchini (23); these sample sizes are as follows: 1,734,340 (SU psychopathology-related), 1,164,731 (Non-SU internalizing), and 730,198 (Non-SU externalizing). After performing Q-SNP analysis, 1,720 Q-SNPs were removed, leaving 1,557,030 SNPs for analysis. No gene-set associations passed Bonferroni corrections in the MAGMA gene-set analysis. In the MAGMA gene-property tissue expression analyses, pituitary, cortex and cerebellum brain tissues were implicated, as well as early-mid-prenatal developmental stage.

LABEL:

MAGMA genes associated with non-SU EXT factor_pvalue

SCORE TYPE:

P-Value

THRESHOLD:

<= 0.5

GENES IN THRESHOLD:

9002

DATE ADDED:

2025-01-17

DATE UPDATED:

2025-07-14

SPECIES:

AUTHORS:

Leslie A Brick, Chelsie E Benca-Bachman, Emma C Johnson, Daniel E Gustavson, Matthew Carper, Rohan Hc Palmer

TITLE:

Genetic associations among internalizing and externalizing traits with polysubstance use among young adults.

JOURNAL:

medRxiv : the preprint server for health sciences Apr 2023, Vol , pp.

ABSTRACT:

Though most genetic studies of substance use focus on specific substances in isolation or generalized vulnerability across multiple substances, few studies to date focus on the concurrent use of two or more substances within a specified time frame (i.e., polysubstance use; PSU). We evaluated whether distinct genetic factors underlying internalizing and externalizing traits were associated with past 30-day PSU above variance shared across general psychopathology and substance use (SU). Using Genomic Structural Equation Modeling, we constructed theory-driven, multivariate genetic factors of 16 internalizing, externalizing, and SU traits using genome-wide association studies (GWAS) summary statistics. Next, we fit a model with a higher order SU-related psychopathology factor as well as genetic variance specific to externalizing and internalizing (i.e., residual genetic variance not explained by SU or general psychopathology). GWAS-by-subtraction was used to obtain single nucleotide polymorphism effects on each of these factors. Polygenic scores (PGS) were then created in an independent target sample with data on PSU, the National Longitudinal Study of Adolescent to Adult Health. To evaluate the effect of genetic variance due to internalizing and externalizing traits independent of variance related to SU, we regressed PSU on the PGSs, controlling for sex, age, and genetic principal components. PGSs for SU-related psychopathology and non-SU externalizing traits were associated with higher PSU factor scores, while the non-SU internalizing PGS was not significantly associated with PSU. In total, the three PGSs accounted for an additional 4% of the variance in PSU above and beyond a null model with only age, sex, and genetic principal components as predictors. These findings suggest that there may be unique genetic variance in externalizing traits contributing to liability for PSU that is independent of the genetic variance shared with SU. PUBMED: 37066212
Find other GeneSets from this publication

Annotation Information

No sequence read archive data associated with this GeneSet.


Behavior (D001519)
Demography (D003710)
Longitudinal Studies (D008137)
Substance-Related Disorders (D019966)
Smoking (D012907)
Genome-Wide Association Study (D055106)
Attention (D001288)
Attention Deficit Disorder with Hyperactivity (D001289)
Adolescent (D000293)
Tissues (D014024)
Nucleotides (D009711)
Alcoholics (D057229)
Cerebellum (D002531)
Sexual Partners (D012747)
Biological Specimen Banks (D018070)
Psychopathology (D011599)
Antisocial Personality Disorder (D000987)
Cannabis (D002188)
Polymorphism, Single Nucleotide (D020641)
Association (D001244)
Sample Size (D018401)
cerebellum (MA:0000198)
hyperactivity (MP:0001399)
Genetic variation (EDAM_topic:0199)
Transcriptomics (EDAM_topic:0203)
Nucleic acid features (SNP) (EDAM_data:2092)
Electron microscopy (EDAM_topic:0611)
imazamox-ammonium (CHEBI:133232)
androsta-1,4-diene-3,17-dione (CHEBI:40799)
advanced glycation end-product (CHEBI:84123)
L-selenomethionine residue (CHEBI:30019)
nucleotide (CHEBI:36976)
Hyperactivity (HP:0000752)
attention deficit hyperactivity disorder (DOID:1094)
smoking initiation (EFO:0005670)
developmental stage (EFO:0000399)
smoking behavior (EFO:0004318)
attention deficit hyperactivity disorder (EFO:0003888)
Cannabis use (EFO:0007585)
nicotine dependence (EFO:0003768)
Caucasian (EFO:0003156)
life cycle stage (UBERON:0000105)
adult organism (UBERON:0007023)
pituitary gland (UBERON:0000007)
adult cerebral ganglion (UBERON:6110636)

Gene List • 14909 Genes

Genes in threshold: 9002

Uploaded As Gene Symbol Homology Score Priority LinkOuts Emphasis